Vincent J B, Klempan T, Parikh S S, Sasaki T, Meltzer H Y, Sirugo G, Cola P, Petronis A, Kennedy J L
Clarke Institute of Psychiatry, Neurogenetics Section, University of Toronto, ON, Canada.
Mol Psychiatry. 1996 May;1(2):141-8.
Much interest has recently been focussed on the possibility of the involvement of unstable DNA in the etiology of schizophrenia and bipolar affective disorder (BPAD), following several publications that report increases in frequency of large CAG/CTG repeats in affected individuals. Using the Repeat Expansion Detection (RED) technique, we have performed a matched control pair analysis for both disorders. No significant differences in CAG/CTG repeat sizes were observed for 52 bipolar affecteds and matched controls (P = 0.15), and borderline significance was observed for 54 schizophrenia affecteds and matched controls (P = 0.05), using a (CTG)10 oligonucleotide (one-tailed t-tests for paired samples). Furthermore, using a (CTG)17 oligonucleotide, no significant differences were observed for 58 bipolar affecteds and 55 schizophrenia affecteds compared to 81 unmatched controls. No significant sex effect was observed for either group, and no significant differences in repeat size were found for responders and non-responders to drug treatments. More importantly, there was no significant correlation (either positive or negative) between age of onset of disease and size of repeat. We thus cannot conclude that CAG/CTG trinucleotides are involved in psychotic disorders and that either the differences observed in similar studies may be the result of population stratification, or that the increased frequency of larger repeats amongst affected individuals is a much smaller effect than previously thought.
最近,在几篇报道称受影响个体中大型CAG/CTG重复序列频率增加的论文发表之后,人们对不稳定DNA参与精神分裂症和双相情感障碍(BPAD)病因的可能性产生了浓厚兴趣。我们使用重复序列扩增检测(RED)技术,对这两种疾病进行了配对对照分析。使用(CTG)10寡核苷酸(配对样本单尾t检验),在52名双相情感障碍患者及其配对对照中,未观察到CAG/CTG重复序列大小的显著差异(P = 0.15);在54名精神分裂症患者及其配对对照中观察到临界显著性(P = 0.05)。此外,使用(CTG)17寡核苷酸,与81名非配对对照相比,58名双相情感障碍患者和55名精神分裂症患者中未观察到显著差异。两组均未观察到显著的性别效应,药物治疗的应答者和非应答者在重复序列大小上也未发现显著差异。更重要的是,疾病发病年龄与重复序列大小之间没有显著的相关性(无论是正相关还是负相关)。因此,我们不能得出CAG/CTG三核苷酸参与精神障碍的结论,类似研究中观察到的差异可能是群体分层的结果,或者受影响个体中较大重复序列频率的增加比之前认为的影响要小得多。